Cancer Research Technology
Log in Register
Menu

VLS-VSCC cell line

Invented by Daniela Elena Costea , Harsh Dongre , Line Bjørge
Invented at University of Bergen , Haukeland University Hospital

Info

Catalogue Number 160853
Synonyms UB-VCC1
Host Human
Disease Keywords Vulvar lichen sclerosus and vulva squamous cell carcinoma
Model Cancer Model
Relevance Currently, there are no in vitro models to study VSCC-VLS. This is the first cell line modelling this disease.
Production Details Spontaneously immortalized, i.e without any additional genetic alterations
Conditional No
Research Area Cancer
Growth/Phenotype Keywords Doubling time: 18.90 ± 0.53 hours
Recommended Growing Conditions DMEM/Nutrient Mixture F-12 Ham medium (D8437, Sigma) supplemented with 10% NBCS, 1X Insulin-Transferrin-Selenium (41400-04, Thermofisher Scientific), 0.4 ug/mL hydrocortisone (H0888, Sigma), 50ug/mL L-ascorbic acid (A7631, Sigma), and 10ng/mL epidermal growth factor (E9644, Sigma)
Notes A novel spontaneously immortalized cell line established from vulva squamous cell carcinoma associated with lichen sclerosus
Cellosaurus ID CVCL_YD88

References

There are 1 reference entries for this reagent.

View All References

References: 1 entry

Dongre et al. 2020. Exp Cell Res. 386(1):111684. PMID: 31654625.


Add a reference

References: 1 entry

Dongre et al. 2020. Exp Cell Res. 386(1):111684. PMID: 31654625.


Add a reference

Inventor Information